Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
A single-pill combination of amlodipine besylate and atorvastatin calcium
R Blank
, Frederick Hobbs
, J Zamorano
, X Girerd
Research output
:
Contribution to journal
›
Article
11
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A single-pill combination of amlodipine besylate and atorvastatin calcium'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Atorvastatin
100%
Amlodipine
100%
Single-pill Combination
100%
Amlodipine Besylate
100%
Atorvastatin Calcium
100%
Cardiovascular Events
66%
Hypertensive Patients
50%
Single pill
50%
Europe
16%
Clinical Trials
16%
Cardiovascular Risk
16%
Risk Factors
16%
Safety Profile
16%
Parent Compounds
16%
Highly Effective
16%
Potential Gains
16%
Cholesterol Levels
16%
Blood Pressure Lowering
16%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
Calcium Channel Blockers
16%
Blood Lipids
16%
Statins
16%
Prescription Drug Costs
16%
National Guidelines
16%
Incremental Risk
16%
Elevated Cholesterol
16%
Blood Pressure Target
16%
Lipid-lowering
16%
High Cardiovascular Risk
16%
Anti-atherosclerosis
16%
Blood Pressure-lowering Agents
16%
Clinical Profile
16%
Lipid Targets
16%
Combination pill
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atorvastatin
100%
Amlodipine Besylate
100%
Amlodipine
75%
Cardiovascular Risk
25%
Clinical Trial
12%
Low Density Lipoprotein Cholesterol
12%
Calcium Channel Blocker
12%
Hypercholesterolemia
12%
Statin (Protein)
12%